PI
ALT icon

PEAK6 Investments’s Altimmune ALT Stock Holding History

PEAK6 Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,400
Closed -$122K – 3433
2024
Q2 		$122K Buy
+18,400
New +$136K ﹤0.01% 2957
2023
Q2 		– Sell
-2,600
Closed -$11K – 3878
2023
Q1 		$11K Buy
+2,600
New +$30.9K ﹤0.01% 3959

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PEAK6 Investments's ALT Position: Q3 2024 in Review

PEAK6 Investments sold out of Altimmune (ALT) in Q3 2024, closing a stake of 18,400 shares — an estimated $122K sold.

PEAK6 Investments first reported a position in ALT in Q1 2023 and held it in 2 quarters. The position peaked at $122K in Q2 2024. 169 funds tracked by Wall St. Rank hold ALT as of Q3 2024.

  • PEAK6 Investments reported no remaining Altimmune position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 18,400 Altimmune shares in Q3 2024, an estimated $122K.
  • PEAK6 Investments first reported a position in Altimmune in Q1 2023 and held it in 2 quarters.
  • PEAK6 Investments's Altimmune position peaked at $122K in Q2 2024.
  • 169 funds tracked by Wall St. Rank held Altimmune as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.